|AS Olainfarm -- Germany Stock|| |
EUR 8.8 0.09 1.01%
Director of Research and Development Department
Mr. Vilnis Liepins serves as Director of Research and DevelopmentDepartment of Joint stock company Olainfarm. He has more than a 15year long experience in the field of chemistry and pharmaceutics. He joined JSC Olainfarm in 2013, when he transferred from Syntagon Baltic Ltd., where he was the Group Leader. He obtained his doctoral degree at Stockholms universitet and did his internship at the MaxPlanck Institute in Germany. He obtained a masters degree in organic chemistry and a bachelors degree in chemical technology at Rigas Tehniska universitate .
The company has return on total asset (ROA)
of 6.33 %
which means that it generated profit of $6.33 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE)
of 12.08 %
meaning that it generated $12.08 on every $100 dollars invested by stockholders.
The company has accumulated 28.23 M in total debt with debt to equity ratio (D/E) of 30.3 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. AS Olainfarm has Current Ratio of 1.92 which is within standard range for the sector.
AS Olainfarm (UU4) is traded on Frankfurt Stock Exchange in Germany. and employs 25 people.